When you have tried different siRNA sequences, optimized experimental conditions, and verified your controls, but the knockdown efficiency remains unsatisfactory, there is no need to keep struggling with siRNA alone. This article introduces three established alternative approaches and provides a comprehensive troubleshooting quick-reference table covering the entire series to help you identify the most suitable solution.

First, Consider: How Much Knockdown Efficiency Is "Good Enough"?

Knockdown efficiency varies depending on the cell type and target gene, and there is no universally applicable threshold. The key criterion is whether the phenotype of interest can be consistently reproduced, rather than whether the numerical knockdown efficiency appears impressive.

Approach 1: Change the Sequence or Pool Multiple siRNAs

If satisfactory knockdown efficiency cannot be achieved despite repeated optimization of experimental conditions and replacement of siRNA sequences, consider the following options:

· Use an siRNA sequence that produces the desired phenotypic change. A sequence that reliably generates the expected phenotype may be suitable for further experiments;

· Pool multiple siRNAs for transfection while maintaining the same total siRNA concentration. This may improve target gene knockdown and reduce the concentration-dependent off-target effects associated with individual sequences;

Approach 2: Change the Delivery Method

In many cases, poor knockdown efficiency is not caused by the siRNA sequence itself but by inefficient delivery.

· Difficult-to-transfect cells (such as stem cells, suspension cells, and primary cells): Consider electroporation or viral delivery of shRNA;

· Nuclear-localized lncRNAs: Although lncRNAs are transcribed in the nucleus, their final subcellular localization varies. Some are distributed in the cytoplasm, others remain in the nucleus, and some are present in both compartments. For cytoplasmic lncRNAs, conventional RNA interference methods such as siRNA can generally achieve knockdown. However, because siRNA and shRNA primarily function in the cytoplasm, many nuclear-localized lncRNAs are difficult to knock down effectively. In such cases, antisense oligonucleotides (ASOs) may be used to target nuclear lncRNAs, or CRISPR-based approaches may be employed to disrupt the corresponding genomic locus.

▎ Practical Expectations for Nuclear-Localized lncRNAs

Although some studies have reported successful shRNA-mediated knockdown of nuclear lncRNAs, the core components of the RNAi machinery are predominantly enriched in the cytoplasm, making nuclear targets more challenging. If your target is a nuclear-localized lncRNA, it is advisable to evaluate ASO or CRISPR-based strategies early in the experimental planning stage to avoid repeated unsuccessful siRNA optimization attempts.

Approach 3: Direct Gene Knockout — Achieving Loss of Function at the Genomic Level

If the experimental objective requires complete loss of function, a long-term stable phenotype, or involves a target that is unsuitable for RNA interference, CRISPR/Cas9 technology can be used to directly disrupt the target gene at the genomic level. Unlike RNAi-mediated knockdown, gene knockout introduces permanent genomic alterations and does not require continuous transfection to maintain the genetic modification. However, complete functional loss should be experimentally verified.

How to Choose Among the Three Approaches

Comprehensive Troubleshooting Quick-Reference Guide

The following table summarizes all the issues discussed in the four articles of this series, allowing you to quickly identify potential causes and corresponding troubleshooting strategies based on observed experimental results.